Conferences

8
May

SID2019: Preserving skin integrity and metabolism

SID2019: Genoskin validates skin integrity and metabolism at 10 days with Promega Glucose-Glo™ and Lac­tate-Glo™ Assays Genoskin’s team of skin experts will be presenting its latest work at the 77th SID Annual Meeting from May 8 to May 11 in Chicago. To learn more about our live human skin models and R&D services, swing by booth #106. Our Chief Commercial
Read more
29
Apr

Come and meet the team at SID2019 in Chicago

Genoskin to attend the 77th Annual Meeting of the Society for Investigative Dermatology  The 77th Annual Meeting of the Society for Investigative Dermatology (SID2019) is a knowledge hub that connects a diverse group of senior researchers, clinicians and clinical trainees. The SID Meeting appears as a premier forum for the exchange of knowledge in various disciplines, from Dermatology and Immunology
Read more
22
Apr

HypoSkin® presented at New Frontiers in 3D in Cambridge, MA

Genoskin presents its subcutaneous injection model HypoSkin® at New Frontiers in 3D Genoskin’s CEO Pascal Descargues, PhD will attend scientific symposium New Frontiers in 3D at the MIT Samberg Center in Cambridge, MA, USA. Take the opportunity to discover our unique subcutaneous injection model through a poster presentation.   Hyposkin®, a unique human skin model to study subcutaneous injection Poster
Read more
7
Mar

Unique subcutaneous injection model at SOT meeting in Baltimore

Genoskin presents unique subcutaneous injection model at SOT Baltimore The Genoskin team spreads its wings: in March, you'll find us at the Society of Toxicology's Annual Meeting in Baltimore, US, where we'll present our new HypoSkin model to test the efficacy and toxicity of subcutaneous injections on live human skin models.   Unique tools to test human skin response to all
Read more
9
May

Genoskin in Florida to attend IID 2018

Genoskin to attend International Investigative Dermatology Meeting in Orlando, Florida IID is a leading event in the field of dermatology. The 2018 edition will take place from May 16th to 19th at the Rosen Shingle Creek Resort. Genoskin’s CEO Pascal Descargues, PhD as well as Project Manager Emeline Pages, PhD, Team Leader Claire Jardet, PhD and Business Developer Michael Pastore, PharmD/PhD will attend the International
Read more
2
Mar

DBV’s immunotherapy tested on Genoskin’s skin models

DBV Technologies' epicutaneous immunotherapy tested using NativeSkin® ex vivo human skin Latest results to be presented at the AAAAI/WAO Joint Congress in Orlando The poster "Epicutaneous immunotherapy with peanut directly targets Langerhans cells in human skin" (n° 723, session  4204) will be presented at the American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in Orlando, Florida on
Read more